AMGN vs RMD
By Alex · Tickerpine
Amgen Inc. vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | RMD |
|---|---|---|
| Price | $416.18 | $226.00 |
| Market cap | $225.15B | $32.78B |
| P/E ratio | 25.7 | 21.5 |
| ROE | 91.47% | 24.27% |
| Profit margin | 22.95% | 26.95% |
| Revenue growth | 9.50% | 8.60% |
| Dividend yield | 2.43% | 1.17% |
| Beta | 0.41 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs RMD in plain English
- AMGN is the bigger company — about 6.9× the market cap of RMD.
- RMD is cheaper on earnings (P/E 21.5 vs 25.7).
- AMGN earns a higher return on equity (91% vs 24%).
- AMGN is growing revenue faster (10% vs 9%).
- AMGN has the higher dividend yield (2.43% vs 1.17%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.